Unconfigured Ad

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts
  • swaraj
    Member
    • Feb 2012
    • 50

    Coverage

    Dear All,
    I am curious to know for a RNAseq experiment what would be the ideal statistics to measure the coverage of reads across known features. The options I am confused with are whether I should go with coverage of complete transcripts or simply work on the coverage of exons. Also there are some transcripts which have high coverage on only one of the exons hence how to interpret such results.
  • swaraj
    Member
    • Feb 2012
    • 50

    #2
    Also I would like to know whether I can use a coverage cut-off to select for the expression of a transcript.

    Comment

    • westerman
      Rick Westerman
      • Jun 2008
      • 1104

      #3
      Transcripts. FPKM, not coverage. Even if you are not using the program, see the cufflinks manual for a good explanation and a reference. http://cufflinks.cbcb.umd.edu/howitworks.html

      Comment

      • swaraj
        Member
        • Feb 2012
        • 50

        #4
        I am working with non-coding transcripts for whom the FPKM as reported by cufflinks is very low. Many times the FPKM value reported is zero whilst I see coverage of the built transcripts. This behaviour may be because some classes of non-coding transcripts are be expressed in a small spatio-temporal window. Hence my question, that whether I can use some score like coverage or read count instead of FPKM to monitor such transcripts. My apologies for not elaborating on the context of the question before.

        Comment

        • westerman
          Rick Westerman
          • Jun 2008
          • 1104

          #5
          Originally posted by swaraj View Post
          I am working with non-coding transcripts for whom the FPKM as reported by cufflinks is very low. Many times the FPKM value reported is zero whilst I see coverage of the built transcripts. This behaviour may be because some classes of non-coding transcripts are be expressed in a small spatio-temporal window. Hence my question, that whether I can use some score like coverage or read count instead of FPKM to monitor such transcripts. My apologies for not elaborating on the context of the question before.
          I guess I am at a loss as to what you are asking. Certainly you can use read counts. I have done so many times. Statistically you will probably run into problems proving anything from them (especially if they are low) unless you are working in a binary on-off situation.

          Assuming that you are not in a binary situation then with zero FPKMs and low counts then you are in the "noise level". Using the counts as a way to point towards other experiments is acceptable. Using the counts in a paper would be tricky since I would expect the reviewers to question any conclusion made from noisy data.

          Comment

          • swaraj
            Member
            • Feb 2012
            • 50

            #6
            Thanks a lot for your valuable suggestions. I will keep them in mind.

            Comment

            Latest Articles

            Collapse

            • SEQadmin2
              Proteomic Platforms: How to Choose the Right Analytical Strategy to Improve Detection and Clinical Applications
              by SEQadmin2


              Proteomics platforms are evolving rapidly, with advances in mass spectrometry and affinity-based approaches expanding what researchers can detect and at what scale. As the field moves toward deeper proteome coverage and clinical applications, scientists face an increasingly complex landscape of tools. This article will explore how researchers are navigating these choices to find the right platform for their work.

              The systematic characterization of the human proteome has
              ...
              07-20-2026, 11:48 AM
            • SEQadmin2
              Advanced Sequencing Platforms Tackle Neuroscience’s Toughest Genomics Problems
              by SEQadmin2



              Genomics studies in neuroscience face a special challenge due to the brain’s complexity and scarcity of samples. Mapping changes in cell type and state using conventional next-generation sequencing methods remains challenging. Advances in technologies like single-cell sequencing, spatial transcriptomics, and long-read sequencing have opened the door to deeper studies of the brain and diseases like Alzheimer’s, amyotrophic lateral sclerosis (ALS), and schizophrenia.
              ...
              07-09-2026, 11:10 AM
            • SEQadmin2
              Cancer Drug Resistance: The Lingering Barrier to Rising Survival
              by SEQadmin2



              Cancer survival rates have significantly increased in the last few decades in the United States, reaching a combined 70% 5-year survival rate by 2021. Behind this number, there are years of research to find new therapies, drug targets, and early detection methods. But there is one core challenge that keeps slowing down these advances, and it’s about drug resistance.

              There is no single reason why many patients don’t respond to treatment as expected. Cancer is...
              07-08-2026, 05:17 AM

            ad_right_rmr

            Collapse

            News

            Collapse

            Topics Statistics Last Post
            Started by SEQadmin2, 07-24-2026, 12:17 PM
            0 responses
            16 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-23-2026, 11:41 AM
            0 responses
            18 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-20-2026, 11:10 AM
            0 responses
            24 views
            0 reactions
            Last Post SEQadmin2  
            Started by SEQadmin2, 07-13-2026, 10:26 AM
            0 responses
            37 views
            0 reactions
            Last Post SEQadmin2  
            Working...